Lithium in the treatment of periodic catatonia: a case report

Wald, David S; Lerner, Jacob

doi:10.1176/ajp.135.6.751

Cited by 17 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of topiramate ( 119 ) and carbamazepine ( 120 ) has also been reported. Although lithium has been anecdotally reported to have a beneficial effect on acute catatonic symptoms ( 121 , 122 ), it is mostly described to be of use in the prevention of recurrent catatonia ( 121 , 123 – 127 ), albeit with sometimes limited results ( 123 ).…”

Section: Treatment Of Catatoniamentioning

confidence: 99%

A Clinical Review of the Treatment of Catatonia

Sienaert¹,

Dhossche²,

Vancampfort³

et al. 2014

Front. Psychiatry

234

312

View full text Add to dashboard Cite

Catatonia is a severe motor syndrome with an estimated prevalence among psychiatric inpatients of about 10%. At times, it is life-threatening especially in its malignant form when complicated by fever and autonomic disturbances. Catatonia can accompany many different psychiatric illnesses and somatic diseases. In order to recognize the catatonic syndrome, apart from thorough and repeated observation, a clinical examination is needed. A screening instrument, such as the Bush-Francis Catatonia Rating Scale, can guide the clinician through the neuropsychiatric examination. Although severe and life-threatening, catatonia has a good prognosis. Research on the treatment of catatonia is scarce, but there is overwhelming clinical evidence of the efficacy of benzodiazepines, such as lorazepam, and electroconvulsive therapy.

show abstract

Section: Treatment Of Catatoniamentioning

confidence: 99%

A Clinical Review of the Treatment of Catatonia

Sienaert¹,

Dhossche²,

Vancampfort³

et al. 2014

Front. Psychiatry

234

312

View full text Add to dashboard Cite

show abstract

“…There is also the important issue of maintenance treatment to prevent catatonic episodes. Lithium is the most frequently reported agent used in the maintenance of periodic catatonia, but even this evidence relies only on case reports and small case series ( Gjessing, 1967 ; Padhy et al, 2011 ; Petursson, 1976 ; Sato et al, 2020 ; Sovner and McHugh, 1974 ; Wald and Lerner, 1978 ). Case reports have reported success with mirtazapine ( Yeh et al, 2010 ) and clomipramine ( Barroso Cañizares et al, 1999 ) in the maintenance treatment of periodic catatonia in patients with depressive disorder ( Yeh et al, 2010 ).…”

Section: Subtypes Of Catatonia and Related Conditionsmentioning

confidence: 99%

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

et al. 2023

View full text Add to dashboard Cite

The British Association for Psychopharmacology developed an evidence-based consensus guideline on the management of catatonia. A group of international experts from a wide range of disciplines was assembled. Evidence was gathered from existing systematic reviews and the primary literature. Recommendations were made on the basis of this evidence and were graded in terms of their strength. The guideline initially covers the diagnosis, aetiology, clinical features and descriptive epidemiology of catatonia. Clinical assessments, including history, physical examination and investigations are then considered. Treatment with benzodiazepines, electroconvulsive therapy and other pharmacological and neuromodulatory therapies is covered. Special regard is given to periodic catatonia, malignant catatonia, neuroleptic malignant syndrome and antipsychotic-induced catatonia. There is attention to the needs of particular groups, namely children and adolescents, older adults, women in the perinatal period, people with autism spectrum disorder and those with certain medical conditions. Clinical trials were uncommon, and the recommendations in this guideline are mainly informed by small observational studies, case series and case reports, which highlights the need for randomised controlled trials and prospective cohort studies in this area.

show abstract

Unusual Presentations of Schizophrenia

Lesser

1982

Extraordinary Disorders of Human Behavior

View full text Add to dashboard Cite

Lithium in the treatment of periodic catatonia: a case report

Cited by 17 publications

References 9 publications

A Clinical Review of the Treatment of Catatonia

A Clinical Review of the Treatment of Catatonia

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

Unusual Presentations of Schizophrenia

Contact Info

Product

Resources

About